Member Info for Baffyman

Correct, read the info, then make your own mind up is my take on it.

He does try to put negatives in as well, so he's well balanced in his views imo.

PS Forgot:

AND it opens up a massive platform if successful.

What makes me laugh about Trinity, is that they use all sorts of technically deep analysis, then they stick there wet finger in the air and state 10% COS.

Further to this, lower down in the report, they say "ah but it should only be 5%, we are generous and say 10%"

NO real negatives for this 40 year old drug in AVCT trials yet, 10%....GET REAL.

Another green box creating a stupid heading.

Jealousy is the main reason that a nobody condemns someone who puts some effort in.

AS made a big point of saying that no news means we are still working behind the scenes.

Think it was reference to his impatience with the unreasonable fluctuating share price.

Take it as a bonus, as stated in DTW's last note, the fundamentals are better now than a few months ago.

I see it as an opportunity to stack up more shares at bargain basement, as I didn't expect less than 150 p anymore.

Effectively they start selling the shares 5 trading days before they get them through an agreement with the mm's I.e 18th April.
And yes it's a right con.

Zero left imo.
Don't forget they usually start selling on a T+5 basis, this has happened many times on other shares.
Ps they always sell in blocks then an odd number to finish with to complete the selling.

Well spotted

ditto, hope it is.

Like this bit of RNS:
"HURO have also recently launched "SPEROMED", a nasal spray healthcare retail product that is based on the SPOR-COV technology designed in Vietnam and is marketed under Vietnamese regulations. Destiny Pharma and SporeGen will receive royalties on sales."
Know its only Vietnam, but at least some money will come in from this.

Note out from them today, still has 279p target.

But this shows that there is a current stream of tech going on in the background to enhance use of affimers, at Uni level.
Yes AVCT should push affimers that they have preclinic, but the future also important.

Sorry Korriban, didn't see your comment until after reply, so not addressed at you.

Alextak, good link and is a positive move forward where affimers can be used instead of animals in early lab research.
This would be good news to many animal welfare groups and ought to receive the positive press it should.
Yet another good piece to put in the jigsaw of AVCT.

Surely all good news is of interest to investors and helpful to get the company noticed.
From your comments it appears that you are a trader.
As always though, dyor and make your own mind up on ALL investments

https://youtu.be/hE5QkZj0RIg
Really well explained.
Mind blowing potential

If its a 200k buy at 123.75, where are the 200k sells on the other side of the trade at less than 123.75p?.
Must be a sell imo Heights

Looks like sell at 123p this morning at 0818hrs has closed the gap, so onwards we go junkie.

Great find gmcc, good potential for Dx.

Howzaty, don't agree.
Avacta precision targets FAPalpha enzyme in a tumour and is not patient specific, but tumour specific.
Precsion medicine is a tailored medicine for the individual, based on their requirements.
Not great explanations but that's 3 attempts at me explaining the difference, so no more on this from me.